Exercise program aims to reverse Hospital-Related muscle loss in kidney patients

NCT ID NCT06607913

Recruiting now Disease control Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 16-week exercise program can help older adults with chronic kidney disease regain muscle and strength after being in the hospital. Researchers will use ultrasound and strength tests to measure changes. The goal is to find better ways to help patients recover and stay independent.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Exercise (supervised and home-based resistance training)
What this could lead to: If successful, this could point toward a standard exercise program to help older adults with kidney disease recover muscle and function after hospitalization.
What could go wrong: This is an early-stage study with no control group comparison for the exercise itself. Results may not apply to all patients, and adherence to home exercise may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE (CKD)

Contacts and locations

Locations

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
RECRUITING

Baltimore, Maryland, 21201, United States
Rocky Mountain Regional VA Medical Center, Aurora, CO
RECRUITING

Aurora, Colorado, 80045-7211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.